Metagenics Chief Science Officer, Jeffrey Bland, PhD, FACN, CNS Appointed to Advisory Board of HealthCorps®
San Clemente, Calif. (July 1, 2009) - Metagenics, Inc. announced today that its Chief Science Officer, Jeffrey Bland, PhD, FACN, CNS has been appointed to the Advisory Board of HealthCorps®, a 501(c)(3) non-profit “Peace Corps” for health education and activism founded in 2004 by cardiac surgeon and best-selling author, Dr. Mehmet Oz..
As a member of the Advisory Board, Dr. Bland joins a distinguished group of health experts, public officials and philanthropists who share the mission of finding proactive, practical solutions to fighting childhood obesity and diabetes. According to the U.S. Centers for Disease Control and Prevention, 13 percent of high school students are obese and at high risk to develop type 2 diabetes or other serious diseases.
To deliver its curriculum, HealthCorps relies on a team of “Coordinators”—recent college graduates who have deferred medical school or graduate health programs in order to participate in public service. Each Coordinator works within his or her community to:
- Deliver school-based health education and mentoring, as well as community events and outreach to undeserved populations
- Empower teens to become educated consumers and health activists
- Encourage students to develop positive behavioral shifts that will enhance their self-esteem and mental resilience
Since 2004, HealthCorps has spread from a single school in New York City to an extensive network of 44 schools on both coasts.
“I’m honored to be associated with such an admirable organization as HealthCorps,” said Dr. Bland. “Their enthusiasm and achievements are a bright light in the battle against childhood obesity and lifestyle related chronic diseases.”
About Metagenics, Inc.
Metagenics, headquartered in San Clemente, CA, is a global life sciences company focused on reversing chronic illness and improving health. Founded in 1983, the company serves tens of thousands of health care professionals and more than a million patients throughout the world and holds more than 40 propriety formula patents for use in nutraceuticals, medical foods, and pharmaceuticals. Today, Metagenics continues its leadership role by successfully merging the disciplines of nutritional genomics, functional medicine, and therapeutic lifestyle change programs to find solutions to society’s most pressing health concerns. For more information, please visit http://www.metagenics.com.
####
Company contact:
Joseline L. Davison
Corporate Communications
Metagenics, Inc.
949-369-3406
Back to Press Releases

